Duncan established and leads the Early Phase Clinical Trials Team in the CCTC. He has a special interest in novel therapeutic approaches for the treatment of patients with pancreatic cancer. He is the current co-lead of the CRUK Cambridge Centre Pancreatic Cancer Programme. Duncan is also the Chief Investigator for the ATRiUM trial.
